Menu

Markets

Research

News

Learn

AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

REGENXBIO Inc. RGNX

Full chart Compare
Set alert

Price alert · RGNX

All alert types
8.13 USD +0.51 (+6.69%)

Nov 9, 2026, 11:03 AM EST

7.47 Day range 8.15
5.46 52-week range 16.19
YTD
-43.54%
1 year
-27.48%

Financial health

Altman Z-Score

-2.76 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

5 / 9 Average

Nine pass/fail tests of profitability, leverage and efficiency.

Rating

C-1 / 5 overall

  • DCF 1
  • Return on Equity 1
  • Return on Assets 1
  • Debt / Equity 2
  • P/E 1
  • P/B 2

Valuation

P/E -3.8×
FY 2016: -7.8×FY 2017: -13.6×FY 2018: 15.4×FY 2019: -15.9×FY 2020: -15.2×FY 2021: 10.9×FY 2022: -3.5×FY 2023: -3.0×FY 2024: -1.7×FY 2025: -3.8×
FY 2016 5y median -3.0× FY 2025
P/S 4.4×
FY 2016: 107×FY 2017: 95.5×FY 2018: 7.0×FY 2019: 42.7×FY 2020: 10.9×FY 2021: 3.0×FY 2022: 8.7×FY 2023: 8.7×FY 2024: 4.6×FY 2025: 4.4×
FY 2016 5y median 4.6× FY 2025
P/B 7.2×
FY 2016: 3.0×FY 2017: 5.4×FY 2018: 3.0×FY 2019: 3.3×FY 2020: 4.5×FY 2021: 1.8×FY 2022: 1.9×FY 2023: 2.5×FY 2024: 1.5×FY 2025: 7.2×
FY 2016 5y median 1.9× FY 2025
P/FCF -5.9×
FY 2016: -8.6×FY 2017: -15.2×FY 2018: 16.8×FY 2019: -12.6×FY 2020: -20.9×FY 2021: 10.3×FY 2022: -4.1×FY 2023: -3.4×FY 2024: -2.2×FY 2025: -5.9×
FY 2016 5y median -3.4× FY 2025
EV/EBITDA -7.3×
FY 2016: -7.2×FY 2017: -12.9×FY 2018: 15.9×FY 2019: -16.0×FY 2020: -14.7×FY 2021: 6.4×FY 2022: -4.0×FY 2023: -3.5×FY 2024: -2.1×FY 2025: -7.3×
FY 2016 5y median -3.5× FY 2025
EV/Sales 5.7×
FY 2016: 101×FY 2017: 91.1×FY 2018: 6.7×FY 2019: 41.0×FY 2020: 9.2×FY 2021: 2.4×FY 2022: 8.7×FY 2023: 9.3×FY 2024: 4.9×FY 2025: 5.7×
FY 2016 5y median 5.7× FY 2025
FCF Yield -17.0%
FY 2016: -11.6%FY 2017: -6.6%FY 2018: 5.9%FY 2019: -7.9%FY 2020: -4.8%FY 2021: 9.7%FY 2022: -24.3%FY 2023: -29.1%FY 2024: -45.9%FY 2025: -17.0%
FY 2016 5y median -24.3% FY 2025

Profitability

Gross Margin 88.1%
FY 2016: 79.1%FY 2017: 83.6%FY 2018: 95.6%FY 2019: 76.6%FY 2020: 76.9%FY 2021: 89.0%FY 2022: 51.6%FY 2023: 58.8%FY 2024: 59.7%FY 2025: 88.1%
FY 2016 5y median 59.7% FY 2025
Operating Margin -94.6%
FY 2016: -1423.8%FY 2017: -730.2%FY 2018: 40.3%FY 2019: -422.9%FY 2020: -77.1%FY 2021: 34.0%FY 2022: -233.2%FY 2023: -297.1%FY 2024: -280.0%FY 2025: -94.6%
FY 2016 5y median -233.2% FY 2025
Net Margin -113.8%
FY 2016: -1372.1%FY 2017: -704.0%FY 2018: 45.7%FY 2019: -268.9%FY 2020: -72.0%FY 2021: 27.2%FY 2022: -248.7%FY 2023: -292.0%FY 2024: -272.5%FY 2025: -113.8%
FY 2016 5y median -248.7% FY 2025
ROE -188.7%
FY 2016: -38.9%FY 2017: -40.0%FY 2018: 19.6%FY 2019: -21.0%FY 2020: -29.5%FY 2021: 16.7%FY 2022: -54.3%FY 2023: -84.5%FY 2024: -87.5%FY 2025: -188.7%
FY 2016 5y median -84.5% FY 2025
ROIC -42.1%
FY 2016: -39.8%FY 2017: -41.2%FY 2018: 16.2%FY 2019: -31.0%FY 2020: -18.9%FY 2021: 14.7%FY 2022: -37.1%FY 2023: -59.4%FY 2024: -62.9%FY 2025: -42.1%
FY 2016 5y median -42.1% FY 2025
ROA -42.8%
FY 2016: -36.5%FY 2017: -36.8%FY 2018: 18.4%FY 2019: -19.0%FY 2020: -15.7%FY 2021: 11.5%FY 2022: -33.6%FY 2023: -45.9%FY 2024: -48.7%FY 2025: -42.8%
FY 2016 5y median -42.8% FY 2025

Growth (YoY)

Revenue 104.5%
FY 2016: -39.5%FY 2017: 126.5%FY 2018: 2002.4%FY 2019: -83.9%FY 2020: 338.7%FY 2021: 204.3%FY 2022: -76.0%FY 2023: -19.9%FY 2024: -7.7%FY 2025: 104.5%
FY 2016 FY 2025
Operating Income 30.9%
FY 2016: -182.4%FY 2017: -16.1%FY 2018: 216.1%FY 2019: -269.1%FY 2020: 20.0%FY 2021: 234.2%FY 2022: -264.3%FY 2023: -2.0%FY 2024: 13.0%FY 2025: 30.9%
FY 2016 FY 2025
EPS (diluted) 18.1%
FY 2016: 4.4%FY 2017: -2.9%FY 2018: 211.4%FY 2019: -194.5%FY 2020: -15.5%FY 2021: 197.7%FY 2022: -323.4%FY 2023: 7.4%FY 2024: 23.8%FY 2025: 18.1%
FY 2016 FY 2025
Free Cash Flow 28.0%
FY 2016: -146.2%FY 2017: -14.9%FY 2018: 240.2%FY 2019: -230.7%FY 2020: 32.2%FY 2021: 266.4%FY 2022: -276.8%FY 2023: 4.1%FY 2024: 23.1%FY 2025: 28.0%
FY 2016 FY 2025

Financial Health

Current Ratio 2.4×
FY 2016: 9.7×FY 2017: 11.6×FY 2018: 15.2×FY 2019: 10.2×FY 2020: 6.5×FY 2021: 4.0×FY 2022: 3.2×FY 2023: 2.6×FY 2024: 2.7×FY 2025: 2.4×
FY 2016 5y median 2.7× FY 2025
Quick Ratio 2.4×
FY 2016: 9.5×FY 2017: 11.3×FY 2018: 15.0×FY 2019: 10.2×FY 2020: 6.4×FY 2021: 4.0×FY 2022: 3.2×FY 2023: 2.6×FY 2024: 2.7×FY 2025: 2.4×
FY 2016 5y median 2.7× FY 2025
Debt / Equity 2.5×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.2×FY 2021: 0.1×FY 2022: 0.2×FY 2023: 0.3×FY 2024: 0.3×FY 2025: 2.5×
FY 2016 5y median 0.3× FY 2025
Net Debt / EBITDA -1.7×
FY 2016: 0.4×FY 2017: 0.6×FY 2018: -0.8×FY 2019: 0.6×FY 2020: 2.7×FY 2021: -1.5×FY 2022: 0.0×FY 2023: -0.2×FY 2024: -0.1×FY 2025: -1.7×
FY 2016 5y median -0.2× FY 2025
Interest Coverage -3.6×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: -155×FY 2021: 6.1×FY 2022: -11.3×FY 2023: -39.1×FY 2024: -18.4×FY 2025: -3.6×
FY 2016 5y median -11.3× FY 2025

Dividends

Dividend Yield 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31